Yat Sun Or
2012
In 2012, Yat Sun Or earned a total compensation of $606.1K as Senior Vice President, Research Development and Chief Scientific Officer at Enanta Pharmaceuticals, a 20% increase compared to previous year.
Compensation breakdown
Bonus | $136,569 |
---|---|
Option Awards | $143,704 |
Salary | $321,415 |
Other | $4,439 |
Total | $606,127 |
Or received $321.4K in salary, accounting for 53% of the total pay in 2012.
Or also received $136.6K in bonus, $143.7K in option awards and $4.4K in other compensation.
Rankings
In 2012, Yat Sun Or's compensation ranked 8,092nd out of 11,487 executives tracked by ExecPay. In other words, Or earned more than 29.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,092 | 30th |
Manufacturing | 2,922 | 31st |
Chemicals And Allied Products | 771 | 36th |
Drugs | 549 | 41st |
Pharmaceutical Preparations | 430 | 38th |
Or's colleagues
We found two more compensation records of executives who worked with Yat Sun Or at Enanta Pharmaceuticals in 2012.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019